Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2024 07:00 ET | Source: Oxford BioMedica plc

Update to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary Results

Update to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary Results Three-year revenue CAGR increased to more than 35%, up from prior guidance of more than 30%Projected FY2024...